Endocrine-disrupting effects of bisphenols on urological cancers

Environ Res. 2021 Apr:195:110485. doi: 10.1016/j.envres.2020.110485. Epub 2020 Nov 16.

Abstract

Bisphenols are endocrine-disrupting chemicals found in a broad range of products that can modulate hormonal signalling pathways and various other biological functions. These compounds can bind steroid receptors, e.g. estrogen and androgen receptors, expressed by numerous cells and tissues, including the prostate and the bladder, with the potential to alter their homeostasis and normal physiological functions. In the past years, exposure to bisphenols was linked to cancer progression and metastasis. As such, recent pieces of evidence suggest that endocrine-disrupting chemicals can lead to the development of prostate cancer. Moreover, bisphenols are found in the urine of the wide majority of the population. They could potentially affect the bladder's normal physiology and cancer development, even if the bladder is not recognized as a hormone-sensitive tissue. This review will focus on prostate and bladder malignancies, two urological cancers that share standard carcinogenic processes. The description of the underlying mechanisms involved in cell toxicity, and the possible roles of bisphenols in the development of prostate and bladder cancer, could help establish the putative roles of bisphenols on public health.

Keywords: Bisphenol; Bladder; Cancer; Endocrine disruptor; Prostate.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Benzhydryl Compounds
  • Endocrine Disruptors* / toxicity
  • Estrogens
  • Humans
  • Male
  • Signal Transduction
  • Urologic Neoplasms*

Substances

  • Benzhydryl Compounds
  • Endocrine Disruptors
  • Estrogens